Stay updated on Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.

Latest updates to the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page
- Check2 days agoChange DetectedThe study record's contact/sponsor details were updated to separate the investigator's name from the institution, and additional help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study), accompanied by a revision tag (v3.6.0).SummaryDifference2%

- Check9 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a new version of the page content. The change updates the page metadata but does not alter the trial details.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe revision tag on the page has been updated from v3.5.3 to v3.5.4, indicating a new page version. This is a metadata/version update and does not modify the study content or data presented.SummaryDifference0.1%

- Check45 days agoChange DetectedThe page now displays the updated site revision, v3.5.3, replacing the previous v3.5.2; this indicates a software deployment rather than a change to trial information.SummaryDifference0.1%

- Check59 days agoChange Detected- Revision tag updated from v3.5.0 to v3.5.2. This appears to be a minor maintenance update and does not modify study data or visible content.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.1%

Stay in the know with updates to Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib Plus Sintilimab in CRC 3rd-line Clinical Trial page.